Braintree Manufacturing Innovation Centre: A case study in GMP transformational change
Year: 2024
Type: other
Abstract: The Cell and Gene Therapy Catapult’s (CGT Catapult) Braintree Manufacturing Innovation Centre (Braintree MIC) is designed to support cell and gene therapy developers to accelerate the development of their Good Manufacturing Practice (GMP) manufacturing operations for advanced therapies at a clinical and commercial scale. Following a successful inspection by the Medicines and Healthcare products Regulatory Agency (MHRA), Braintree MIC received an MHRA Manufacturers and Importers Authorisation...
Source: Hypotheses (OpenEdition)
DOI: 10.58079/12prs
Author: Adelage
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6918035913
Cites:
Cited by:
Related to: